The ratio of LC3 II and I as well as the expression of Beclin 1 in KCs with knocked-down Bim were significantly lower than in KCs treated with an agonist for Foxo3a and PA and LPS (Figure 3B). The gene discussed is BCL2L11; the disease is dry eye syndrome.